Cadus Pharmaceutical Corp., Bristol-Myers deal

Bristol-Myers exercised its option to extend for two years its 1994

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE